Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-13-031065)

Filing Details

Accession Number:: 0001181431-13-031065
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-05-28 18:40:29
Reporting Period:: 2013-05-23

Filing Date:: 2013-05-28
Accepted Time:: 2013-05-28 18:40:29
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
819050	Vical Inc	VICL	Biological Products, (No Disgnostic Substances) (2836)	930948554

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1201888	C Robert Merton	10390 Pacific Center Court San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock $.01 Par Value	Acquisiton	2013-05-23	5,953	$0.01	75,781	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, $.01 Par Value	Nonstatutory Stock Option (right to buy)	Acquisiton	2013-05-23	39,619	$0.00	39,619	$3.58

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
298,741	2014-05-23	2023-05-22	No	4	A	Direct

Footnotes

Shares were acquired pursuant to a restricted stock grant.
The date in this field is approximate. These options are exercisable at the date of the next annual meeting of stockholders. The date of the meeting has not been set, but is expected to occur in May 2014.
This balance includes 5,953 of unvested restricted stock units.